Amalgamated Bank decreased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 23.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 68,415 shares of the medical instruments supplier’s stock after selling 21,540 shares during the quarter. Amalgamated Bank’s holdings in DENTSPLY SIRONA were worth $2,687,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of XRAY. MetLife Investment Management LLC raised its stake in shares of DENTSPLY SIRONA by 23.1% in the 1st quarter. MetLife Investment Management LLC now owns 59,453 shares of the medical instruments supplier’s stock valued at $2,926,000 after purchasing an additional 11,156 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in shares of DENTSPLY SIRONA by 6.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,250 shares of the medical instruments supplier’s stock valued at $1,440,000 after acquiring an additional 1,811 shares in the last quarter. Raymond James Trust N.A. grew its holdings in shares of DENTSPLY SIRONA by 61.7% in the 1st quarter. Raymond James Trust N.A. now owns 7,042 shares of the medical instruments supplier’s stock valued at $346,000 after acquiring an additional 2,687 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of DENTSPLY SIRONA by 6.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock valued at $90,243,000 after acquiring an additional 117,571 shares in the last quarter. Finally, Sei Investments Co. grew its holdings in shares of DENTSPLY SIRONA by 18.9% in the 1st quarter. Sei Investments Co. now owns 468,759 shares of the medical instruments supplier’s stock valued at $23,090,000 after acquiring an additional 74,629 shares in the last quarter. Institutional investors and hedge funds own 99.68% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on the company. UBS Group raised their price objective on DENTSPLY SIRONA from $43.00 to $46.00 in a report on Friday, May 5th. Morgan Stanley lifted their price target on DENTSPLY SIRONA from $39.00 to $45.00 and gave the stock an “overweight” rating in a report on Wednesday, April 19th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Thursday, July 13th. Robert W. Baird lifted their price target on DENTSPLY SIRONA from $36.00 to $46.00 in a report on Thursday, May 4th. Finally, Barrington Research lifted their price target on DENTSPLY SIRONA from $43.00 to $51.00 in a report on Thursday, May 4th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $42.13.
Insider Buying and Selling at DENTSPLY SIRONA
DENTSPLY SIRONA Trading Up 0.9 %
Shares of NASDAQ:XRAY opened at $41.03 on Friday. DENTSPLY SIRONA Inc. has a 12-month low of $26.48 and a 12-month high of $43.24. The business has a 50 day moving average of $39.23 and a 200-day moving average of $38.67. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.93 and a current ratio of 1.41.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its quarterly earnings results on Wednesday, May 3rd. The medical instruments supplier reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.05. DENTSPLY SIRONA had a negative net margin of 26.41% and a positive return on equity of 8.65%. The company had revenue of $978.00 million during the quarter, compared to the consensus estimate of $938.16 million. During the same period in the previous year, the business earned $0.52 earnings per share. The firm’s quarterly revenue was up .9% on a year-over-year basis. On average, equities analysts predict that DENTSPLY SIRONA Inc. will post 1.92 earnings per share for the current year.
DENTSPLY SIRONA Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, July 14th. Stockholders of record on Friday, June 30th were given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 1.36%. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend was Thursday, June 29th.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.
Featured Articles
- Five stocks we like better than DENTSPLY SIRONA
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Can SAIA Continue its Stratospheric Rally?
- How to Capture the Benefits of Dividend Increases
- Why Markets Are Loving Exxon Mobil, Despite The Earnings Dip
- How to Invest in Insurance Companies: A Guide
- 7 Best Industrial REITs to Buy Now
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
